Clinical trial Recruiting at 1 site Observational Ages 31 to 79

Multimodal prospective cohort of Parkinsonism

Official title: A Multimodal Prospective Cohort Study of Parkinsonism

Run by Ruijin Hospital · NCT07553845 · Data updated 2026-11-12

This project will try to track disease progression and improve diagnosis using imaging, clinical tests, and biological samples in people with parkinsonism, people with REM sleep behavior disorder, and healthy volunteers over five years.

Quick facts

Study typeObservational
Ages31 Years to 79 Years
SexAll
Enrollment640 (estimated)
SponsorRuijin Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedMay 1, 2024
Main results expectedMay 2029
Study endsMay 2029
Registry record updatedApril 28, 2026
Trial IDNCT07553845 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese adults aged over 30 and under 80 who can provide informed consent and either meet standard diagnostic criteria for parkinsonism or for RBD, or are healthy controls without neurological disease.

Probably not a fit

People outside the 30–80 age range, non-Chinese citizens, those unable to comply with repeated visits or follow-up, or individuals with severe comorbidities or contraindications to imaging are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective observational cohort enrolling 400 participants with parkinsonism, 120 with REM sleep behavior disorder (RBD), and 120 healthy controls with five years of follow-up. Participants will undergo multimodal assessments including neuroimaging, clinical rating scales, blood and other biological samples, cerebral blood flow testing, neurophysiology, tremor analysis, and voice/video recordings. The study aims to characterize longitudinal progression, identify factors linked to conversion from RBD to parkinsonism, and improve differentiation among parkinsonian disorders. All procedures are observational and designed to build biomarkers and diagnostic signatures rather than test an experimental treatment.

Why it matters

Potential benefit: If successful, the work could help clinicians diagnose different parkinsonian disorders earlier and predict which people with RBD are likely to develop parkinsonism.

How similar studies have gone: Similar longitudinal multimodal cohort studies in Parkinson's disease and RBD have shown some success in identifying potential biomarkers and predictors of conversion, though robust, universally accepted diagnostic markers are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For participants with rapid eye movement sleep behavior disorder:

* Meets the diagnostic criteria for rapid eye movement sleep behavior disorder established by the American Academy of Sleep Medicine
* Chinese citizen
* Age \>30 years and \<80 years
* Able to understand the study, show good compliance, and provide written informed consent personally or through a legal representative

For participants with Parkinsonism:

* Meets the diagnostic criteria for Parkinsonism established by the International Parkinson and Movement Disorder Society
* Chinese citizen
* Age \>30 years and \<80 years
* Able to understand the study, show good compliance, and provide written informed consent personally or through a legal representative

For healthy controls:

* No neurodegenerative disease, no history of head trauma or head surgery, no history of stroke, epilepsy, tumor, or psychiatric disease
* No metal implants or cardiac pacemaker
* No severe chronic disease or severe hepatic or renal insufficiency
* Chinese citizen
* Age \>30 years and \<80 years
* Education level of primary school or above
* Able to understand the study, show good compliance, and provide written informed consent personally or through a legal representative

Exclusion Criteria:

* Significant cognitive impairment (MMSE ≤23)
* Unable to sign the informed consent form or unable to complete study procedures for other reasons
* Any other condition that, in the opinion of the investigator, makes the participant unsuitable for this study

Where it's running

  • Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.